Star Wars Eclipse sounded like a promising science-fiction adventure story when it was first revealed, but now its future is ...

Thinking about learning Python coding online? It’s a solid choice. Python is pretty straightforward to pick up, and you can do a lot with it. Whether you’re just curious or looking to build something ...

OpenAI said it will acquire Astral, a startup that builds tools for software developers. Astral's team will join OpenAI as part of the group running its AI coding assistant, Codex. OpenAI has been ...

Ever thought what turns a good idea into a working application? The short and simple answer to this question is selecting the right framework. As Python has gained popularity among web development ...

Eclipse Advantage announced the launch of a Skilled Staffing service aimed at helping companies address ongoing labor shortages in technical trades. The new service expands the company’s workforce ...

The Hacker News is the top cybersecurity news platform, delivering real-time updates, threat intelligence, data breach reports, expert analysis, and actionable insights for infosec professionals and ...

GitHub's Octoverse 2025 data shows TypeScript became the most-used language as 80% of new developers adopt Copilot within their first week. TypeScript has dethroned both Python and JavaScript to ...

Learn how gradient descent really works by building it step by step in Python. No libraries, no shortcuts—just pure math and code made simple. Automatic registration for US military draft to begin in ...

Philadelphia-based development company Eclipse Development recently acquired a prime Fishtown development site and is planning a four-story mixed-use building there, writes Paul Schwedelson for the ...

Vir Biotechnology, Inc. (Nasdaq: VIR) today announced that the Company has granted Norgine Pharma UK Limited, an affiliate of Norgine, a leading European specialty pharmaceutical company, an exclusive ...

– Vir Biotechnology (VIR) to receive EUR 55 million initial reimbursement payment upon closing, and up to EUR 495 million in clinical, regulatory and sales milestones, along with tiered, mid-teen to ...